Of note, the overexpression of insulin-like growth factor binding protein 2 (IGFBP-2) in glioblastoma tumour tissue has been repeatedly reported and is associated with shorter patient survival [5,6,7,8,9]. This evidence concerns the gene IGFBP2 and glioblastoma.